Rani Therapeutics reported Q3 2026 financial results, highlighting acceptance into the FDA's Emerging Technology Program to support its RaniPill oral biologics platform. The company has $45.3 million in cash and expects to fund operations through 2027. Enrollment continues in the RT-114 Phase 1a study, with data expected by year-end. This progress underscores Rani's potential to replace injectable biologics with oral alternatives and advance manufacturing automation for clinical development.
Rani Therapeutics' Q3 2026 financial update provides context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 10, 2026 04:11 WIB: out of 150 priced health-sector US stocks, 125 rose and 23 fell. Notable gainers include TXG at USD 65.27 with a 10.10% increase, DNA at USD 12.41 up 9.92%, and SMMT at USD 17.90 rising 9.61%.
AmpliTech Group, a company specializing in RF and microwave components for telecom and defense, will announce its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a conference call at 5:00 PM ET the...
Toll Brothers has announced the grand opening of new luxury single-story model homes at Hidden Vista, a gated community in Palm Desert, California, on November 14. These homes offer up to 2,700 sq ft with 3-4 bedrooms, modern open floor plans, and pr...
FocusReactive, a web development agency specializing in Next.js and headless CMS, achieved top rankings across six major industry review platforms in 2026, including Clutch, DesignRush, and The Manifest. The agency was recognized globally for experti...
Indonesia's e-commerce market is projected to grow from $120.2 billion in 2027 to $239.4 billion by 2032, with a CAGR of 14.78%. Growth is fueled by rising mobile commerce adoption, live-stream shopping, digital payment solutions like PayLater, and e...
Security National Financial Corporation reported a 38.6% drop in after-tax earnings for Q3 2026, falling to $6.17 million due to challenging mortgage market conditions and increased interest rates. The mortgage segment faced a $2.65 million loss driv...
